glp-1 long-term side effects 🎙️New Podcast Episode drugs are being called a “miracle”—but what are the risks most people aren't being told? Watch the full episode on YouTube: https://youtu.be/KFsLHaZep_s #GLP1 #WeightLoss #MetabolicHealth Eli Lilly strikes Zepbound $20 - $30 Quantity:1 Month Supply (90 Count)

glp-1 long-term side effects 🎙️New Podcast Episode drugs are being called a “miracle”—but what are the risks most people aren't being told? Watch the full episode on YouTube: https://youtu.be/KFsLHaZep_s #GLP1 #WeightLoss #MetabolicHealth Eli Lilly strikes Zepbound $20 - $30 Quantity:1 Month Supply (90 Count)

Eli Lilly strikes Zepbound deal with Ro, amid questions on compounded GLP-1s

He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance

$20 - $30

Quantity:1 Month Supply (90 Count)

Daniel Barasa Sarah Donnelly Kevin Dreyer 914-921-8384 914-921-5197 914-921-7791 [email protected] [email protected] [email protected] Joseph Gabelli Jeff Jonas, CFA Jennie Tsai 914-921-8331 914-921-5072 914-921-8436 [email protected] [email protected] [email protected] Sara Wojda 44 (0)20 3206 2116 [email protected] ONE CORPORATE CENTER RYE, NY 10580 Gabelli Funds TEL (914) 921-5100 This whitepaper was prepared by Daniel Barasa, Sarah Donnelly, Kevin Dreyer, Joseph Gabelli, Jeff Jonas, CFA, Jennie Tsai and Sara Wojda